IGCS Members and Friends,
I am extremely proud to announce on behalf of the IGCS leadership that the latest Impact Factor for the International Journal of Gynecological Cancer increased from 3.437 to 4.661. This represents a 36% increase over 2020. The publication now ranks 108 of 245 in the Oncology category and 13 of 85 in the Obstetrics & Gynecology category -- it moved from the third to the second quartile in Oncology and from the second to the first quartile in Obstetrics and Gynecology.
Dr. Pedro Ramirez became the IJGC Editor in Chief in January 2019. We’d like to congratulate him on this achievement and applaud the efforts of the Associate Editors, Editorial Board, our Publisher BMJ and the journal's Managing Editor, Lindsey Struckmeyer.
IGCS President Dr. Robert Coleman commented, "I’m incredibly proud to see the high-quality, citable content published in our society’s journal month after month. The publication represents research being conducted around the world highlighting key issues critical to patients not only in developed countries but also in low-resource countries. Sharing experience, posing and answering important hypotheses, and learning about state of gynecologic cancer internationally is so important to our specialty and brings us closer to improving care on a global scale. I’m grateful to all those who contribute to our journal!”
Dr. Pedro Ramirez shares his sentiments: “Our team wishes to thank all who have supported and continue to support our journal and for submitting your research work. We are grateful for the support of the International Gynecologic Cancer Society and the European Society of Gynecological Oncology, as well as our Managing Editors, and our Publisher BMJ. I would also like to personally express my gratitude to our outstanding team of Associate Editors and our Editorial Board.”
IJGC is the scientific publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces.
Make sure you are taking advantage of all the benefits of being a subscriber to IJGC including weekly podcasts with leading experts discussing the latest research in their respective and monthly Zoom journal club discussions where members of our Editorial Board join the authors of IJGC lead articles to discuss and debate their research and other relevant topics in a collegial, informal setting.
Again, congratulations to Pedro and the entire IJGC team!
Mary Eiken, MS
Follow IJGC on Facebook and Twitter to learn about the latest articles, podcasts, journal club discussions and more. Follow the IJGC Fellows on Twitter for additional content.